[Asia Economy Reporter Kwon Jaehee] Intron Bio announced on the 5th that it has signed a trust contract with KB Securities to acquire its own shares worth 3 billion KRW to enhance shareholder value.



The contract period is from the 6th of this month to July 5, 2023.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing